Correction: Effects of regorafenib on the mononuclear/phagocyte system and how these contribute to the inhibition of colorectal tumors in mice
Eur J Med Res
.
2023 Jun 24;28(1):196.
doi: 10.1186/s40001-023-01150-2.
Authors
Sylvia Grünewald
#
1
2
,
Maria Stecklum
#
3
,
Manuel Rizzo
1
,
Jonathan Rathjens
4
,
Lukas Fiebig
1
,
Dieter Zopf
5
6
Affiliations
1
Bayer AG, Berlin, Germany.
2
Nuvisan ICB GmbH, Berlin, Germany.
3
EPO Berlin-Buch GmbH, Berlin, Germany.
4
Chrestos Concept GmbH & Co. KG, Essen, Germany.
5
Bayer AG, Berlin, Germany.
[email protected]
.
6
Nuvisan ICB GmbH, Berlin, Germany.
[email protected]
.
#
Contributed equally.
PMID:
37355645
PMCID:
PMC10290292
DOI:
10.1186/s40001-023-01150-2
No abstract available
Publication types
Published Erratum